Effects of berberine on the secretion of cytokines and expression of genes involved in cell cycle regulation in THP-۱ monocytic cell line
Publish place: Iranian Journal of Basic Medical Sciences، Vol: 20، Issue: 5
Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 121
This Paper With 8 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-20-5_011
تاریخ نمایه سازی: 28 مهر 1400
Abstract:
Objective(s): Current acute myeloid leukemia (AML) therapeutic strategies have irreversible side-effects. Berberine (BBR) is an isoquinoline alkaloid, which has been known as an aryl hydrocarbon receptor (AhR) ligand. AhR is a cytoplasmic receptor, which is involved in the regulation of cellular and immune responses. Here, we investigated the expression profile of genes involved in the cell cycle and different cytokines upon BBR-mediated AhR activation on AML THP-۱ cell line. Materials and Methods: THP-۱ cells and normal monocytes were treated with different concentrations of BBR (۱۰ μM, ۲۵ μM, ۵۰ μM, and ۱۰۰ μM) for ۲۴ and ۴۸ hr. The cell viability was measured by MTT assay. Real-time RT-PCR was conducted to evaluate the expression of AhR, cytochrome P۴۵۰ ۱A۱ (CYP۱A۱), interleukin ۱ beta (IL۱β), p۲۱, p۲۷, cyclin-dependent kinase ۲ (CDK۲) and p۵۳. Cellular expression of AhR was also assessed using immunofluorescence method. ELISA was used to determine the level of IL-۱۰ and IL-۱۲ cytokines. Results: BBR inhibits the proliferation of THP-۱ cells in a dose- and time-dependent manner with minimal toxicity on normal monocytes. Phorbol ۱۲-myristate ۱۳-acetate (PMA) treatment increased the cellular expression of AhR. The AhR target genes (CYP۱A۱, IL۱β) were overexpressed upon BBR treatment. BBR downregulated Cdk۲ and upregulated p۲۱, p۲۷ and p۵۳ genes in THP-۱ cells. IL-۱۰ was significantly increased upon BBR treatment, while IL-۱۲ was not significantly changed in all combinations. Conclusion: BBR could be introduced as an effective chemotherapeutic agent against AML by giving rise to the expression of CDK inhibitors and anti-inflammatory cytokines and downregulation of CDK۲.
Keywords:
Authors
Saeed Mohammadi
Student Research Committee and Department of Molecular Medicine, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran
Fakhri Sadat Seyedhoseini
Infectious Diseases Research Center and Laboratory Science Research Center, Golestan University of Medical Sciences, Gorgan, Iran
Jahanbakhsh Asadi
Department of Clinical Biochemistry, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran
Yaghoub Yazdani
Infectious Diseases Research Center and Laboratory Science Research Center, Golestan University of Medical Sciences, Gorgan, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :